What is the current Price Target for the Akari Therapeutics Plc Sponsored ADR stock?

The average Akari Therapeutics Plc Sponsored ADR target price is $7.14. This is 516.00% higher than the current stock price. The highest price target is 534.11%, the lowest is 509.96%. 3 Analysts have issued a price target Akari Therapeutics Plc Sponsored ADR 2026 .

How high will the Akari Therapeutics Plc Sponsored ADR stock rise?

No reliable answer can be given as to how high the Akari Therapeutics Plc Sponsored ADR stock will rise. The performance of stocks, including the Akari Therapeutics Plc Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Akari Therapeutics Plc Sponsored ADR stock today?

The performance of Akari Therapeutics Plc Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Akari Therapeutics Plc Sponsored ADR stock fall?

The decline in Akari Therapeutics Plc Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Akari Therapeutics Plc Sponsored ADR Forecast, price target & analysts

$1.16

0.93% yesterday

Nasdaq, Jun 27, 10:00 pm CET

ISIN

US00972G1085

Symbol

AKTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Akari Therapeutics Plc Sponsored ADR Target price 2025 - Analyst rating & recommendation

Akari Therapeutics Plc Sponsored ADR Classifications & Recommendation:

Buy

86%

Hold

14%

Akari Therapeutics Plc Sponsored ADR Price Target

Target Price	$7.14
Price	$1.16
Potential	516.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Akari Therapeutics Plc Sponsored ADR 2026 . The average Akari Therapeutics Plc Sponsored ADR target price is $7.14. This is 516.00% register free of charge higher than the current stock price. The highest price target is $7.35 534.11% register free of charge , the lowest is $7.07 509.96% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Akari Therapeutics Plc Sponsored ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Akari Therapeutics Plc Sponsored ADR stock has an average upside potential 2026 of 516.00% register free of charge . Most analysts recommend the Akari Therapeutics Plc Sponsored ADR stock at Purchase.

Discover more stocks with a high price target

Berkshire Hathaway 154,261.00%

Alibaba Group Holding Ltd 1,077.45%

BioNTech SE - ADR 31.42%

Tencent Holdings Ltd. 26.26%

Adyen 24.86%

Deutsche Telekom 24.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today